RESUMO
The metabolism of lysergic acid diethylamide (LSD) to 2-oxo-3-hydroxy lysergic acid diethylamide (O-H-LSD) was investigated in liver microsomes and cyropreserved hepatocytes from humans. Previous studies have demonstrated that O-H-LSD is present in human urine at concentrations 16-43 times greater than LSD, the parent compound. Additionally, these studies have determined that O-H-LSD is not generated during the specimen extraction and analytical processes or due to parent compound degradation in aqueous urine samples. However, these studies have not been conclusive in demonstrating that O-H-LSD is uniquely produced during in vivo metabolism. Phase I drug metabolism was investigated by incubating human liver microsomes and cryopreserved human hepatocytes with LSD. The reaction was quenched at various time points, and the aliquots were extracted using liquid partitioning and analyzed by liquid chromatography-mass spectrometry. O-H-LSD was positively identified in all human liver microsomal and human hepatocyte fractions incubated with LSD. In addition, O-H-LSD was not detected in any microsomal or hepatocyte fraction not treated with LSD nor in LSD specimens devoid of microsomes or hepatocytes. This study provides definitive evidence that O-H-LSD is produced as a metabolic product following incubation of human liver microsomes and hepatocytes with LSD.
Assuntos
Alucinógenos/metabolismo , Hepatócitos/metabolismo , Dietilamida do Ácido Lisérgico/análogos & derivados , Dietilamida do Ácido Lisérgico/metabolismo , Microssomos Hepáticos/metabolismo , Cromatografia Líquida , Criopreservação , Feminino , Humanos , Masculino , Espectrometria de Massas , Detecção do Abuso de Substâncias/métodosRESUMO
Alkylphenol ethoxylates (APEs) and related compounds recently have been reported to be estrogenic because it has been demonstrated in laboratory studies that they mimic the effects of estradiol both in vitro and in vivo. Chemicals referred to as "environmental estrogens" are suspected of causing health effects in both humans and wildlife through disruption of the endocrine system. In this review, the occurrence, environmental fate, and biological effects of APEs are presented. To provide understanding of the potential for endocrine disruption due to environmental estrogens, the physiology of estrogens in mammals and fish is also reviewed. The estrogenic potency of other environmental estrogens is compared to the potency of APE degradation products. The reproductive effects of estrogenic compounds are considered when evaluating the potential health effects of APEs. Given the reported environmental concentrations and bioconcentration factors of APE products, the potential for these compounds to produce estrogenic effects in the environment appears low. Although questions concerning the physiological effects of APEs and other environmental estrogens remain unanswered, there are indications that research is in progress that will lead to better understanding of the risks to humans and wildlife.
Assuntos
Poluentes Ambientais/toxicidade , Estrogênios/toxicidade , Óxido de Etileno/toxicidade , Fenóis/toxicidade , Tensoativos/toxicidade , Animais , Ligação Competitiva , Biodegradação Ambiental , Glândulas Endócrinas/efeitos dos fármacos , Glândulas Endócrinas/metabolismo , Poluentes Ambientais/metabolismo , Estrogênios/metabolismo , Óxido de Etileno/química , Óxido de Etileno/metabolismo , Feminino , Humanos , Masculino , Fenóis/química , Fenóis/metabolismo , Receptores de Estrogênio/efeitos dos fármacos , Receptores de Estrogênio/metabolismo , Medição de Risco , Diferenciação Sexual , Relação Estrutura-Atividade , Tensoativos/metabolismo , Poluentes Químicos da Água/metabolismo , Poluentes Químicos da Água/toxicidadeRESUMO
In teleostean in vivo studies, the vitellogenin response to environmental estrogens is not completely predicted by mammalian literature. One possible explanation for differences is heterogeneity of the estrogen receptor (ER) structure between species. Therefore, ER from channel catfish (Ictalurus punctatus) hepatic tissue was characterized by binding affinity for several compounds. Affinity was indirectly measured as potency of the chemical for inhibiting binding of radiolabeled estradiol (E2) to specific binding sites. The order of potency among therapeutic chemicals was ethinylestradiol > unlabeled E2 = diethylstilbestrol > mestranol > tamoxifen >> testosterone. Unlabeled E2 had an IC50 of 2.2 nM. Several environmentally relevant chemicals were evaluated in a similar manner and the order of potency established was the o-demethylated metabolite of methoxychlor (MXC) > nonylphenol (NP) > chlordecone > MXC > o,p'-DDT > o,p'-DDE > beta-hexachlorocyclohexane. Demethylated MXC had an IC50 1000-fold greater than that of E2. Of the most potent inhibitors, NP appeared to be a competitive inhibitor for the same binding site as E2, while o-demethylated MXC had a more complex interaction with the receptor protein. ER from nonvitellogenic females was determined to have a Kd value of 1.0 to 1.3 nM. Because E2 has been reported to up-regulate teleostean ER, the hepatic ER population following in vivo xenobiotic exposure was assessed. NP significantly increased ER per milligram hepatic protein almost to the same extent as E2, but did not increase Kd to the same extent as E2.
Assuntos
Inseticidas/farmacologia , Fígado/metabolismo , Fenóis/farmacologia , Receptores de Estrogênio/agonistas , Receptores de Estrogênio/metabolismo , Xenobióticos/farmacologia , Animais , Estradiol/farmacologia , Ictaluridae , Fígado/efeitos dos fármacosRESUMO
Direct and indirect measures of growth and energy storage were evaluated as indicators of subchronic 1,1,1-trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane (o,p'-DDT) exposure in juvenile sailfin mollies (Poecilia latipinna). Three-day-old mollies were exposed to 0, 1, 10, 25, 50, 75, and 100 micrograms/liter o,p'-DDT for 21 days. Tissue residues, percentage weight gain, RNA and DNA content, RNA:DNA ratio, percentage total lipid, percentage triglyceride, percentage total protein, and triglyceride:total lipid ratio were measured following exposure. Mortality was concentration and time dependent, with 100% mortality at 75 and 100 micrograms/liter. Among controls and remaining treatments, tissue residues (0.50 to 363 ng/mg dry wt), percentage weight gain (116 to 596%), percentage total lipid (2.84 to 4.33%), and percentage triglyceride (1.01 to 3.22%) were significantly different. Tissue residues were positively correlated with concentration, while percentage weight gain, percentage lipid, percentage triglyceride, and triglyceride:total lipid ratio were negatively correlated with concentration. Direct measures are likely to remain the method of choice for evaluating effects of toxicants on growth in laboratory exposures because of their relative simplicity and reliability. However, indirect measures of energy storage, such as triglyceride:total lipid ratio, rather than direct measures of various lipid fractions may be more reliable indicators of the energetic cost of toxicant stress.
Assuntos
DDT/farmacologia , Metabolismo Energético/efeitos dos fármacos , Poecilia/crescimento & desenvolvimento , Poluentes Químicos da Água/farmacologia , Animais , Biomarcadores , Peso Corporal/efeitos dos fármacos , DDT/análise , Lipídeos/análise , Mortalidade , Ácidos Nucleicos/análise , Ácidos Nucleicos/efeitos dos fármacos , Poecilia/metabolismo , Proteínas/análise , Proteínas/efeitos dos fármacosRESUMO
The organochlorine pesticide methoxychlor [1,1,1-trichloro-2,2-bis(4-methoxyphenyl) ethane] (MXC) has been classified as a proestrogen in mammals and fish, requiring demethylation prior to eliciting estrogenic activity or binding to the estrogen receptor. While microsomal demethylation occurs readily in the liver of fish, little is known about the enzyme(s) responsible or the effect of cytochrome P450 (CYP) inducers, other than those of CYP1A and CYP2K, on biotransformation. Consequently, male channel catfish were pretreated with MXC or beta-naphthoflavone (BNF), alone and in combination, to determine their effects on CYP protein expression, MXC biotransformation by hepatic microsomes, microsomal protein binding, and MXC estrogenic activity as determined by serum vitellogenin and 17beta-estradiol. Liver microsomes of both treated and untreated mature male catfish catalyzed formation of monodemethylated MXC, bisdemethylated MXC, as well as ring-hydroxylated metabolites. Pretreatment with BNF did not affect MXC metabolite profiles, overall rates of MXC biotransformation, or microsomal proteins recognized by anti-trout CYP2K1, but had the expected effect of inducing CYP1A and associated ethoxyresorufin O-deethylase activity. By contrast, pretreatment with MXC, alone or in combination with BNF, significantly reduced rates of MXC biotransformation and binding to liver microsomal protein. MXC/BNF cotreatment followed by MXC significantly induced serum vitellogenin, whereas MXC treatment alone led to a nonsignificant increase in vitellogenin and a significant increase in serum 17beta-estradiol. Thus, estrogenic activity elicited by cotreatment with MXC and BNF can occur despite diminished capacity of liver microsomes to catalyze formation of estrogenic demethylated metabolites or metabolites that bind microsomal protein. Possible mechanisms of MXC-induced attenuation of CYP-dependent metabolism are discussed.
Assuntos
Estrogênios/sangue , Metoxicloro/farmacologia , Metoxicloro/farmacocinética , beta-Naftoflavona/farmacologia , Animais , Biotransformação/efeitos dos fármacos , Sistema Enzimático do Citocromo P-450/biossíntese , Indução Enzimática/efeitos dos fármacos , Estradiol/sangue , Ictaluridae , Injeções Intraperitoneais , Masculino , Metoxicloro/administração & dosagem , Microssomos Hepáticos/efeitos dos fármacos , Microssomos Hepáticos/enzimologia , Vitelogeninas/sangue , beta-Naftoflavona/administração & dosagemRESUMO
Antifungal assay-guided isolation of the 95% ethanol extract of the stems of Colubrina retusa yielded jujubogenin 3-O-alpha-L-arabinofuranosyl(1-->2)-[beta-D-glucopyranosyl (1-->3)]-alpha-L-arabinopyranoside (1), which showed modest growth-inhibitory effects against Candida albicans, Cryptococcus neoformans, and Aspergillus fumigatus (MICs, 50 microg/mL). In addition, two new minor saponins, jujubogenin 3-O-alpha-L-arabinofuranosyl(1-->2)-[2-O-(trans, cis)p-coumaroyl-beta-D-glucopyranosyl(1-->3)]-alpha-L-arabinopy ranosi de (2), and jujubogenin 3-O-(5-O-malonyl)-alpha-L-arabinofuranosyl (1-->2)-[beta-D-glucopyranosyl(1-->3)]-alpha-L-arabinopyranoside (3), were obtained. Saponin 2 was marginally active against only C. neoformans, with a MIC of 50 microg/mL, while 3 was inactive. NMR spectroscopy was used extensively for the structure determination of these compounds. The previously reported ambiguity of the NMR assignments of jujubogenin saponins for carbons -26 to -29 was clarified by a comprehensive analysis of the NMR spectra of 1.
Assuntos
Antifúngicos/farmacologia , Plantas/química , Saponinas/farmacologia , Antifúngicos/isolamento & purificação , Sequência de Carboidratos , Fungos/efeitos dos fármacos , Hidrólise , Espectroscopia de Ressonância Magnética , Testes de Sensibilidade Microbiana , Dados de Sequência Molecular , Caules de Planta/química , Saponinas/isolamento & purificaçãoRESUMO
Two new auronols, amaronols A (1) and B (2), were isolated from the bark of Pseudolarix amabilis, along with pseudolaric acid B (3), pseudolaric acid C (4), demethoxydeacetoxy-pseudolaric acid B (5), pseudolaric acid B-beta-D-glucoside (6), pseudolaric acid A-beta-D-glucoside (7), and myricetin (8). The structures of amaronols A and B were established by spectral data interpretation as 2,4,6-trihydroxy-2-[(3',4',5'-trihydroxyphenyl) methyl]-3(2H)-benzofuranone and 2,4,6-trihydroxy-2-[(3', 5'-dihydroxy-4'-methoxyphenyl) methyl]-3(2H)-benzofuranone, respectively. Antimicrobial testing results of the eight compounds indicated that only pseudolaric acid B was active against Candida albicans (MIC, 3.125 microg/mL; MFC, 6.25 microg/mL), while myricetin was marginally active against Trichophyton mentagrophytes (MIC, 50 microg/mL).
Assuntos
Antifúngicos/farmacologia , Benzofuranos/farmacologia , Cycadopsida/química , Medicamentos de Ervas Chinesas/química , Fenóis/farmacologia , Antifúngicos/química , Antifúngicos/isolamento & purificação , Benzofuranos/química , Benzofuranos/isolamento & purificação , Candida albicans/efeitos dos fármacos , Cromatografia Líquida de Alta Pressão , Espectroscopia de Ressonância Magnética , Espectrometria de Massas , Testes de Sensibilidade Microbiana , Fenóis/química , Fenóis/isolamento & purificação , Espectrofotometria Ultravioleta , Trichophyton/efeitos dos fármacosRESUMO
A new jujubogenin saponin was isolated from the stems of Colubrina retusa and identified as jujubogenin 3-O-alpha-L-arabinofuranosyl (1-->2)-[3-O-(trans)-p-coumaroyl-beta-D-glucopyranosyl (1-->3)]-alpha-L-arabinopyranoside (4) on the basis of chemical and spectroscopic data. The antimycobacterial activity expressed as minimum inhibitory concentration (MIC) for compound 4 was 10 microg/mL.
Assuntos
Antituberculosos/isolamento & purificação , Diterpenos/isolamento & purificação , Oligossacarídeos/isolamento & purificação , Triterpenos , Antituberculosos/química , Antituberculosos/farmacologia , Configuração de Carboidratos , Sequência de Carboidratos , Diterpenos/química , Diterpenos/farmacologia , Espectroscopia de Ressonância Magnética , Espectrometria de Massas , Testes de Sensibilidade Microbiana , Dados de Sequência Molecular , Complexo Mycobacterium avium/efeitos dos fármacos , Oligossacarídeos/química , Oligossacarídeos/farmacologiaRESUMO
Medaka, Oryzias latipes, were exposed in ovo to the polyamine (PA) biosynthesis inhibitors alpha-difluoromethylornithine (DFMO) and methylglyoxal bis(guanylhydrazone) (MGBG). In an additional group, spermine, the end product of the PA pathway, was added with DFMO and MGBG for a "rescue" treatment. At 4 days posthatch, length, DNA and RNA content, and swimming endurance were measured. The only parameter affected by treatment was swimming endurance which revealed decreased latent time to fatigue with increased dose, although not statistically significant. The rescue group, however, did demonstrate a statistically significant decrease in fatigue latency as compared to controls.
Assuntos
Comportamento Animal/efeitos dos fármacos , Eflornitina/farmacologia , Mitoguazona/farmacologia , Óvulo/crescimento & desenvolvimento , Animais , DNA/análise , Oryzias , Óvulo/efeitos dos fármacos , Resistência Física/efeitos dos fármacos , RNA/análise , Fatores de TempoRESUMO
Five prenylated flavonoids, including one new natural product, were isolated from an ethanol extract of the leaves of Maclura tinctoria (L.) Gaud. The new compound has been characterized as 2',4',4,2''-tetrahydroxy-3'-[3''-methylbut-3''-enyl]chalcone (1). The known compounds were identified as 2',4',4-trihydroxy-3'-[3''-methylbut-3''-enyl]chalcone (isobavachalcone) (2), 4,2'-dihydroxy-2''-[1-hydroxy-1-methylethyl]-2'',3''-dihydrofurano[4'',5'':3',4']chalcone (bakuchalcone) (3), 4,4',5''-trihydroxy-6'',6''-dimethyldihydropyrano[2'',3'':5',6'']chalcone (bavachromanol) (4), and 5,7,3',4'-tetrahydroxy-6,8-diprenylisoflavone (6,8-diprenylorobol) (5). All the isolated compounds were evaluated against the AIDS-related opportunistic fungal pathogens, Candida albicans and Cryptococcus neoformans. Compound 2 was active against both yeasts.
Assuntos
Antifúngicos/isolamento & purificação , Candida albicans/efeitos dos fármacos , Chalcona/isolamento & purificação , Cryptococcus neoformans/efeitos dos fármacos , Rosales/química , Antifúngicos/química , Antifúngicos/farmacologia , Chalcona/química , Chalcona/farmacologia , Testes de Sensibilidade Microbiana , Estrutura Molecular , Análise EspectralRESUMO
Bioactivity-guided fractionation of an ethanolic extract of the leaves and twigs of Piper longicaudatum Trelease & Yunker (Piperaceae) resulted in the isolation of one new (1) and three known (2-4) dihydrochalcones. The known compounds are: 2',6'-dihydroxy-4'-methoxydihydrochalcone (2), 2',6',4-trihydroxy-4'-methoxydihydrochalcone (asebogenin) (3), and 2'-hydroxy-4'-methoxy-2'-[1-hydroxy-1-methylethyl]-2",3"-dihy- drofurano[4",5":5',6"]-3"-[2-hydroxy-5-methoxycarbonylphe- nyl]dihydrochalcone (piperaduncin B) (4). The new compound is 2'-hydroxy-4'-methoxy-2"-[2-hydroxy-5-methoxycarbonyl- phenyl]-furano[4",5":5',6']-dihydrochalcone (longicaudatin) (1). Compounds 1-4 were tested for antibacterial activity against S. aureus and methicillin-resistant S. aureus (MRSA); only compound 3 showed inhibitory activity (IC50 of 10 and 4.5 micrograms/ml, respectively).
Assuntos
Alcaloides/isolamento & purificação , Antibacterianos/isolamento & purificação , Chalcona/análogos & derivados , Chalcona/isolamento & purificação , Plantas Medicinais/química , Alcaloides/farmacologia , Antibacterianos/farmacologia , Chalcona/farmacologia , Chalconas , Estrutura Molecular , Folhas de Planta/química , Caules de Planta/química , Staphylococcus aureus/efeitos dos fármacosRESUMO
Assay-guided fractionation of the ethanol extract of the twigs and leaves of Miconia myriantha yielded two new compounds, mattucinol-7-O-[4' ',6' '-O-(S)-hexahydroxydiphenoyl]-beta-D-glucopyranoside (1) and mattucinol-7-O-[4' ',6' '-di-O-galloyl]-beta-D-glucopyranoside (2), along with mattucinol-7-O-beta-D-glucopyranoside (3), ellagic acid (4), 3,3'-di-O-methyl ellagic acid-4-O-beta-D-xylopyranoside, and gallic acid. Complete (1)H and (13)C NMR assignments of compound 1, which possesses a hexahydroxydiphenoyl unit, were achieved using the HMBC technique optimized for small couplings to enhance the four-bond and two-bond H/C correlations. Compounds 1 and 4 showed inhibitory effects against Candida albicans secreted aspartic proteases, with IC(50) of 8.4 and 10.5 microM, respectively.
Assuntos
Glucosídeos/isolamento & purificação , Magnoliopsida/química , Plantas Medicinais/química , Inibidores de Proteases/isolamento & purificação , Ácido Aspártico Endopeptidases/antagonistas & inibidores , Candida albicans/efeitos dos fármacos , Candida albicans/enzimologia , Candida albicans/metabolismo , Cromatografia em Camada Fina , Dicroísmo Circular , Ácido Elágico/química , Ácido Elágico/farmacologia , Ácido Gálico/química , Ácido Gálico/farmacologia , Glucosídeos/química , Glucosídeos/farmacologia , Concentração Inibidora 50 , Espectroscopia de Ressonância Magnética , Espectrometria de Massas , Conformação Molecular , Estrutura Molecular , Pepsina A/antagonistas & inibidores , Peru , Folhas de Planta/química , Inibidores de Proteases/química , Inibidores de Proteases/farmacologia , Espectrofotometria Infravermelho , Espectroscopia de Infravermelho com Transformada de Fourier , Relação Estrutura-AtividadeRESUMO
A novel naphthopyrone derivative, named quinquangulone (1), has been isolated from Cassia quinquangulata, along with the known compounds quinquangulin (2) and its two glycosides (3 and 4), rubrofusarin (5) and its two glycosides (6 and 7), nor-rubrofusarin (8) and its 6-O-glucoside (9), and three stilbenes (10-12). The structure of quinquangulone was established by spectral interpretation as 5,9-dihydroxy-8-methoxy-2,9-dimethyl-6-oxo-4H,6H,9H-naphtho-[2,3-b]pyran-4-one. Reinvestigation of the NMR spectra of quinquangulin led to revision of its structure as 5,6-dihydroxy-8-methoxy-2,9-dimethyl-4H-naphtho[2,3-b]pyran-4-one (2a). The structures of two quinguangulin glycosides, 3 and 4, were also revised accordingly. Compound 2a exhibited activity against Staphylococcus aureus and methicillin-resistant S. aureus (MIC, 3.125 and 6.25 microg/mL, respectively).